Related Experiment Videos
Targeting apoptosis pathways in cancer therapy.
Irene M Ghobrial1, Thomas E Witzig, Alex A Adjei
1Division of Hematology, Department of Internal Medicine, University of Pittsburgh, PA, USA.
CA: a Cancer Journal for Clinicians
|May 14, 2005
Summary
Apoptosis, or programmed cell death, is crucial for controlling cell growth and responding to DNA damage. Novel therapies targeting apoptosis pathways show promise for selective cancer treatment with reduced side effects.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Therapeutics
Background:
- Apoptosis, or programmed cell death, is a fundamental biological process.
- Dysregulation of apoptosis is implicated in cancer development.
- Targeting apoptotic pathways offers a strategy for cancer therapy.
Purpose of the Study:
- To review current understanding of apoptotic pathways.
- To discuss novel agents targeting apoptosis for cancer treatment.
Main Methods:
- Review of scientific literature on apoptosis.
- Analysis of targeted therapies for extrinsic and intrinsic apoptotic pathways.
Main Results:
- Apoptosis involves extrinsic and intrinsic pathways.
- Targeted agents include those acting on TNF receptor 1, Bcl-2 family, p53, NF-kappa B, PI3K, and ubiquitin/proteasome pathways.
- Modulators like bortezomib and mTOR inhibitors are under development.
Conclusions:
- Targeting apoptosis pathways can selectively eliminate cancer cells.
- Potential for therapies that spare normal tissues.
- Ongoing development of novel apoptosis-targeting agents holds therapeutic promise.